News Conference News ACC 2026 Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV Caitlin E. Cox March 30, 2026
News Daily News Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN Yael L. Maxwell February 26, 2026
News Daily News Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators Michael O'Riordan January 22, 2026
News Daily News Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains Caitlin E. Cox December 31, 2025
News Daily News FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement Michael O'Riordan December 23, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Conference News ESC 2025 ESC/EACTS Release New Valvular Heart Disease Guidelines Yael L. Maxwell September 03, 2025
News Conference News NY Valves 2025 Solid, Early Surgical Results With Polymer Mitral Valve Todd Neale July 02, 2025
News Daily News Tendyne Approved in US for High-risk Patients With Mitral Valve Disease Michael O'Riordan May 28, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Conference News PCR London Valves 2024 Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP Michael O'Riordan December 05, 2024
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News NY Valves 2024 Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR Michael O'Riordan June 10, 2024
News Conference News ESC Heart Failure 2024 SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM Michael O'Riordan May 13, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024